Last $103.57 USD
Change Today +0.63 / 0.61%
Volume 680.2K
MJN On Other Exchanges
Symbol
Exchange
Berlin
New York
As of 8:04 PM 10/30/14 All times are local (Market data is delayed by at least 15 minutes).

mead johnson nutrition co (MJN) Snapshot

Open
$102.54
Previous Close
$102.94
Day High
$104.13
Day Low
$102.39
52 Week High
10/17/14 - $104.89
52 Week Low
02/5/14 - $73.23
Market Cap
20.9B
Average Volume 10 Days
2.3M
EPS TTM
$3.26
Shares Outstanding
202.0M
EX-Date
09/11/14
P/E TM
31.8x
Dividend
$1.50
Dividend Yield
1.41%
Current Stock Chart for MEAD JOHNSON NUTRITION CO (MJN)

mead johnson nutrition co (MJN) Details

Mead Johnson Nutrition Company manufactures, distributes, and sells infant formulas, children’s nutrition, and other nutritional products. Its infant formula products include formulas for routine feeding; solutions formulas for addressing mild feeding problems, such as gas/fussiness, soy formula, lactose intolerance, anti-regurgitation, and cow’s milk protein allergy risk; and specialty formula products, including formulas for addressing severe intolerance, formulas for premature and low birth weight infants, and medical nutrition products. Its children’s nutrition products comprise products for meeting children’s nutritional needs at one to three years of age, three to five years of age, and beyond five years of age. The company’s children’s nutrition products also include nutritionally-balanced milk supplements for children targeting nutritional needs during specific stages of development; powered milk supplements; and milk modifiers in powder form. It also produces a range of other products, including pre-natal and post-natal nutritional supplements for expectant and nursing mothers. The company markets its products primarily under the Enfamil Premium, Enfamil Premium Newborn, Enfamil A+, Enfalac A+, Enfapro A+, Enfamil Gentlease, Enfapro Premium, SanCor Bebé, SanCor Bebé Premium, Enfamil ProSobee, Enfamil LactoFree, Enfamil AR, Enfamil HA, Enfamil Comfort, Enfamil for Supplementing, Nutramigen, Nutramigen AA, Pregestimil, Enfamil Premature, Enfacare, Enfagrow, Enfagrow A+, Enfagrow Premium, Enfamil Human Milk Fortifier, Sustagen KID, Lactum, Alacta, ChocoMilk, and Cal-C-Tose brand names. It sells its products to mothers, health care professionals, and retailers in approximately 50 countries in North America, Europe, Asia, and Latin America. The company was founded in 1905 and is headquartered in Glenview, Illinois.

7,200 Employees
Last Reported Date: 02/18/14
Founded in 1905

mead johnson nutrition co (MJN) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $893.8K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $603.8K
Chief Development Officer and Senior Vice Pre...
Total Annual Compensation: $548.0K
Senior Vice President, General Counsel and Se...
Total Annual Compensation: $454.6K
Senior Vice President of Technical Operations
Total Annual Compensation: $377.3K
Compensation as of Fiscal Year 2013.

mead johnson nutrition co (MJN) Key Developments

Mead Johnson Expands Production Capacity at Evansville Facility

Mead Johnson Nutrition Company has expanded its production capacity and capabilities at its facility in Evansville, Indiana. Evansville has been a key facility for Mead Johnson's US product manufacturing for most of the company's history. In fact, next year will mark the 100th anniversary of Mead Johnson's presence in the city.

Mead Johnson Nutrition Company Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014; Re-Affirms Earnings Guidance for 2014

Mead Johnson Nutrition Company announced unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, the company reported total net sales of $1,090.7 million against $1,046.8 million a year ago. Earnings before interest and income taxes (EBIT) were $242.6 million against $250.7 million a year ago. Earnings income taxes (EBT) were $224.3 million against $238.4 million a year ago. Net earnings attributable to shareholders was $187.6 million compared with $171.3 million a year ago. Diluted earnings per share were $0.92 compared with $0.84 a year ago. Non-GAAP net earnings of $0.93 per diluted share for the third quarter of 2014 were in line with the third quarter of 2013. On a non-GAAP basis, net earnings attributable to shareholders totaled $187.9 million, or $0.93 per diluted share, for the third quarter of 2014, compared to $189.7 million, or $0.93 per diluted share, for the same quarter a year ago. For the nine months, the company reported total net sales of $3,315.1 million against $3,140.0 million a year ago. Earnings before interest and income taxes (EBIT) were $778.7 million against $771.0 million a year ago. Earnings before income taxes were $732.7 million against $732.1 million a year ago. Net earnings attributable to shareholders was $561.4 million compared with $531.3 million a year ago. Diluted earnings per share were $2.77 compared with $2.61 a year ago. Net cash provided by operating activates was $564.6 million compared with $592.2 million a year ago. Payments for capital expenditures were $144.0 million compared with $177.3 million a year ago. On a non-GAAP basis, net earnings attributable to shareholders totaled $573.2 million, or $2.83 per diluted share, in the nine months ended September 30, 2014, up 5% from $547.5 million, or $2.69 per diluted share, in the nine months ended September 30, 2013. Free cash flow was about $421 million in the first nine months after consuming $144 million in cash for capital spending. The company re-affirmed its full-year 2014 GAAP EPS guidance, excluding any further pension MTM adjustments, to be in the range of $3.59 to $3.66 per diluted share. Non-GAAP EPS is expected to be in the range of $3.65 to $3.72 per diluted share. Capital spending for the full year is now expected to be around $160 million.

Mead Johnson Nutrition Company Seeks Acquisitions

Mead Johnson Nutrition Company (NYSE:MJN) is seeking acquisitions. Pete Leemputte, Chief Financial Officer of Mead Johnson Nutrition, said, "I think our position is that acquisitions would be the highest use of the cash balances that we have in the Company."

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MJN:US $103.57 USD +0.63

MJN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott India Ltd 3,099 INR +10.30
Inner Mongolia Yili Industrial Group Co Ltd CNY23.99 CNY -0.07
Perrigo Co PLC $161.33 USD +6.33
Hain Celestial Group Inc/The $106.66 USD +0.75
Yakult Honsha Co Ltd ¥6,060 JPY +150.00
View Industry Companies
 

Industry Analysis

MJN

Industry Average

Valuation MJN Industry Range
Price/Earnings 30.8x
Price/Sales 4.8x
Price/Book 40.8x
Price/Cash Flow 30.6x
TEV/Sales 4.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEAD JOHNSON NUTRITION CO, please visit www.mjn.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.